Universe Pharmaceuticals UPC
NASDAQ UPC
$5.30 -0.03 (-0.56%)
As of: Aug 21, 2026 · 3:00 PM EDT

Universe Pharmaceuticals (UPC) Long-Term Investments (2020 - 2026)

Universe Pharmaceuticals (UPC) posted Long-Term Investments of $724848.0 for Q1 2026, up 3.2% sequentially from $702346.0 in Q3 2025.

Universe Pharmaceuticals (UPC) Long-Term Investments (2020 - 2026) Analysis & Trends

Universe Pharmaceuticals has reported Long-Term Investments for 7 years, with the latest figure at $724848.0 in Q1 2026.

  • Quarterly Long-Term Investments changed N/A year-over-year to $724848.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $724848.0 (changed N/A YoY) and the FY2025 annual result came in at $702346.0, down 99.9% from the prior year.
  • Long-Term Investments climbed to $724848.0 in Q1 2026 per UPC's latest filing, from $702346.0 in the prior quarter.
  • Over five years, Long-Term Investments peaked at $712.5 million in Q3 2024 and troughed at $586674.0 in Q1 2022.
  • A 5-year average of $177.4 million and a median of $713869.0 in 2022 frame the typical range for Long-Term Investments.
  • The sharpest annual moves came in 2023 and 2025: Long-Term Investments soared 99822.61% in 2023, then plunged 99.9% in 2025.
  • Over 5 years, Long-Term Investments stood at $702890.0 in 2022, then jumped by 99822.61% to $702.3 million in 2023, then gained by 1.44% to $712.5 million in 2024, then slumped by 99.9% to $702346.0 in 2025, then grew by 3.2% to $724848.0 in 2026.
  • According to Business Quant data, Long-Term Investments over the past three periods registered $724848.0, $702346.0, and $712.5 million for Q1 2026, Q3 2025, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - 92.58 Mn
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 63.23 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 1.14 Bn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 149.10 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 60.00 Mn
10 Universe Pharmaceuticals 2.93 Mn -26.11 Mn - 724,848.00

Historic Data

Download Data
DateValue
Mar 31, 2026 724,848.00
Sep 30, 2025 702,346.00
Sep 30, 2024 712.49 Mn
Mar 31, 2024 692,492.00
Sep 30, 2023 702.35 Mn
Mar 31, 2023 728,055.00
Sep 30, 2022 702,890.00
Mar 31, 2022 586,674.00
Sep 30, 2021 744,924.00
Sep 30, 2020 735.00 Bn